Jefferson's Scleroderma Center offers an exceptional level of clinical focus on this prevalent and debilitating disease, as
well as on Raynaud's disease and related disorders. Staffed by physicians who are world leaders in their field, the center
treats a large patient group with both established medical therapies and experimental treatments. It coordinates the expert
evaluation and management of various organ systems that may be affected by scleroderma, as well as the performance of numerous
clinical and basic science research projects aimed at discovering the cause of the disease and effective treatments. Jefferson’s
Scleroderma Center participates in national and international clinical trials of the latest therapies for the disease, including
bone marrow transplantation.
What is Scleroderma (Systemic Sclerosis)?
Current Research Projects
Congratulations to our Director, Sergio A. Jimenez, M.D., who recently received the Charles H. Slocumb Award for excellence in rheumatology and the very prestigious honor of being named an American College of Rheumatology Master for his distinguished career as a researcher and clinician in the molecular biology of rheumatological diseases.
Philadelphia Top Hospitals
 |
Jefferson's Scleroderma Center has been recognized as a Center of Excellence (2008) and Top Hospital for the "Best Care in Philadelphia" (2003) by Philadelphia Magazine. According to the magazine, “The patient roster reads like a United Nations roll call” and the Center’s director, “international
expert Sergio Jimenez, probably knows more about the disease than anyone in the world…”
|
